Search research articles
Contact Us
Filters
Showing results (21-30 of 92) with videos related to
Page
of 10
Sort By:
The International Journal of Biological Markers
|
September 1, 1986
Serum CA 15.3 levels in patients with non-tumoral diseases, and establishment of a threshold for tumoral activity. Results in 1219 patients
A Ruibal, J Genollá, M Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors
D Castellano, R Hitt, E Ciruelos, et al.
Cell Proliferation
|
January 24, 2008
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A Vazquez-Martin, R Colomer, J Brunet, et al.
Bulletin Du Cancer
|
January 1, 1986
Serum CA 15.3 levels in patients with general pathology and malignant diseases (excluding breast cancer)
A Ruibal, G Encabo, J Genollá, et al.
The International Journal of Biological Markers
|
May 1, 1986
Circulating CA 15.3 levels in breast cancer. Our present experience
R Colomer, A Ruibal, M Navarro, et al.
Clinical Chemistry
|
May 1, 1986
Concentration of myelin basic protein in cerebrospinal fluid in prognosis of multiple sclerosis
J Matias-Guiu, A Ruibal, J M Martinez-Vazquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2008
Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cells
A Vazquez-Martin, C Oliveras-Ferraros, R Colomer, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
September 13, 2001
Prognostic value of cytosolic p53 protein in breast cancer
S Montero, C Guzmán, C Vargas, et al.
Anticancer Research
|
July 1, 1986
CA 15.3: early results of a new breast cancer marker
R Colomer, L A Sole, M Navarro, et al.
British Journal of Cancer
|
January 1, 1997
Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma
R Colomer, J Aparicio, S Montero, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 92) with videos related to
Sort By:
Page
of 10
The International Journal of Biological Markers
|
September 1, 1986
Serum CA 15.3 levels in patients with non-tumoral diseases, and establishment of a threshold for tumoral activity. Results in 1219 patients
A Ruibal, J Genollá, M Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors
D Castellano, R Hitt, E Ciruelos, et al.
Cell Proliferation
|
January 24, 2008
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A Vazquez-Martin, R Colomer, J Brunet, et al.
Bulletin Du Cancer
|
January 1, 1986
Serum CA 15.3 levels in patients with general pathology and malignant diseases (excluding breast cancer)
A Ruibal, G Encabo, J Genollá, et al.
The International Journal of Biological Markers
|
May 1, 1986
Circulating CA 15.3 levels in breast cancer. Our present experience
R Colomer, A Ruibal, M Navarro, et al.
Clinical Chemistry
|
May 1, 1986
Concentration of myelin basic protein in cerebrospinal fluid in prognosis of multiple sclerosis
J Matias-Guiu, A Ruibal, J M Martinez-Vazquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2008
Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cells
A Vazquez-Martin, C Oliveras-Ferraros, R Colomer, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
September 13, 2001
Prognostic value of cytosolic p53 protein in breast cancer
S Montero, C Guzmán, C Vargas, et al.
Anticancer Research
|
July 1, 1986
CA 15.3: early results of a new breast cancer marker
R Colomer, L A Sole, M Navarro, et al.
British Journal of Cancer
|
January 1, 1997
Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma
R Colomer, J Aparicio, S Montero, et al.
Page
of 10